1-4 of 4
Carolyn Jackson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur, Richard T. Maziarz, Natalie Callander, Adam S. Sperling, Carolina Schinke, Andrzej J Jakubowiak, Noa Biran, Douglas W Sborov, Cindy Varga, Abhinav Deol, Abraham S. Kanate, Mehmet Hakan Koçoğlu, Melhem M. Solh, Kamalika Banerjee, Rebecca Chan, Myrna Nahas, Ana Kostic, Enrique Granados, Carolyn Jackson, Christopher R. Heery, Tim Welliver, Krina K. Patel, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2024-198499
Published: 2024
Journal Articles

Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma Who Have Been Previously Treated with Intravenous Daratumumab to Evaluate Retreatment (LYNX)

Nizar Bahlis, MD, Jeffrey A. Zonder, Susan Wroblewski, PhD, Ming Qi, MD PhD, Thomas Renaud, Carolyn Jackson, Thierry Facon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1831.
https://doi.org/10.1182/blood-2019-123486
Published: 2019
Journal Articles

Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma

Nitya Gulati, MBBS, Farid Boulad, MD, Maria I. Cancio, MD, Kevin J. Curran, MD, Carolyn Jackson, Nancy Kernan, MD, Andrew L. Kung, MD PhD, Richard O'Reilly, MD, Susan Prockop, MD, Kavitha Ramaswamy, MD, Andromachi Scaradavou, MD, Barbara Spitzer, Neerav Shukla, MD, Peter G. Steinherz, MD, Christopher Forlenza
Journal: Blood
Blood (2017) 130 (Supplement 1): 5172.
https://doi.org/10.1182/blood.V130.Suppl_1.5172.5172
Published: 2017
Journal Articles

High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL

Kevin J. Curran, MD, Steven P. Margossian, MD PhD, Nancy A. Kernan, MD, Lewis B. Silverman, MD, Jae H. Park, MD, Craig S. Sauter, MD, Eric L Smith, MDPhD, Farid Boulad, MD, Maria I. Cancio, MD, Christopher Forlenza, Carolyn Jackson, Neerav Shukla, MD, Barbara Spitzer, Susan Prockop, MD, Peter G. Steinherz, MD, Andrew L. Kung, MD PhD, Richard J. O'Reilly, MD, Isabelle Riviere, PhD, Michel Sadelain, MD PhD, Renier J. Brentjens, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1326.
https://doi.org/10.1182/blood.V130.Suppl_1.1326.1326
Published: 2017